A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Thomas E. Witzig, Craig B. Reeder, Betsy LaPlant, +9

Leukemia

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation

Mamta Gupta, Jing Han, Mary Stenson, +6

Blood

Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2

Mamta Gupta, Stephen M. Ansell, Anne J. Novak, +3

Blood

BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells

Su Chu, Melissa Holtz, Mamta Gupta, +1

Blood

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

Stephen M. Ansell, Hui Tang, Paul J. Kurtin, +9

The Lancet Oncology

Lymphoid NeoplasiaMedicineImmunologyPathologyLymphatic Disease +3

The Long Non-Coding RNA GAS5 Cooperates with the Eukaryotic Translation Initiation Factor 4E to Regulate c-Myc Translation

Guangzhen Hu, Zhenkun Lou, Mamta Gupta

PLoS ONE

EngineeringImmunologyMolecular BiologyC-myc ProteinMolecular Genetics +14

Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy

Mamta Gupta, Jingjing Han, Mary Stenson, +2

Leukemia

Hematological MalignancyHistone Deacetylase-3Lymphoid NeoplasiaImmunologyMedicine +3

Gadd45a and Gadd45b Protect Hematopoietic Cells from UV-induced Apoptosis via Distinct Signaling Pathways, including p38 Activation and JNK Inhibition

Mamta Gupta, Shiv K. Gupta, Barbara Hoffman, +1

Journal of Biological Chemistry

RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2

Ujwal Dahal, Kang Le, Mamta Gupta

Melanoma Research

ImmunologyMolecular BiologyCancer BiologyMelanoma CellsTumor Biology +16

Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer

Douglass W. Tucker, Christopher R. Getchell, Eric T. McCarthy, +21

Clinical Cancer Research